← Eichor
Study identifier: NCT07021079 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Muscle Vibration as a Countermeasure Against Hypoactivity-induced

Condition: Vibration Therapy · Healthy Volunteer Study · Hypoactivity  ·  Sponsor: Centre Hospitalier Universitaire de Saint Etienne

PhaseNA
Planned participants42
Who can joinAll sexes, 19 Years to 45 Years
Healthy volunteersYes

About this study

Muscle deconditioning, characterized by a loss of muscle mass and strength, is a frequent consequence of prolonged lower limb unloading. Beyond muscle mass loss, reduced neural drive contributes significantly to strength decline, highlighting the need for interventions targeting neuromuscular function during immobilization. Focal muscle vibration (FMV) has shown promise in modulating neuromuscular excitability by activating muscle spindle afferents and inducing cortical adaptations. Chronic use of FMV has been associated with significant strength gains and improved neural command. This makes FMV an effective rehabilitation tool. Its simplicity and non-invasiveness further make it a practical countermeasure.

This description comes directly from the study's public registry record.

Talk to the study team

LEONARD FEASSON, PHD  ·  (0)477120383  ·  leonard.feasson@chu-st-etienne.fr

Always discuss trial participation with your own doctor first.

Locations (1)

Centre Hospitalier UniversitaireSaint-Etienne, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07021079